Epistatic and independent functions of Caspase-3 and Bcl-X <sub>L</sub> in developmental programmed cell death

  • K. A. Roth
    Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110; Section of Immunobiology, Howard Hughes Medical Institute, and Section of Neurobiology, Yale University School of Medicine, New Haven, CT 06510; and Vertex Pharmaceuticals, Inc., Cambridge, MA 02139
  • C.-Y. Kuan
    Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110; Section of Immunobiology, Howard Hughes Medical Institute, and Section of Neurobiology, Yale University School of Medicine, New Haven, CT 06510; and Vertex Pharmaceuticals, Inc., Cambridge, MA 02139
  • T. F. Haydar
    Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110; Section of Immunobiology, Howard Hughes Medical Institute, and Section of Neurobiology, Yale University School of Medicine, New Haven, CT 06510; and Vertex Pharmaceuticals, Inc., Cambridge, MA 02139
  • C. D'Sa-Eipper
    Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110; Section of Immunobiology, Howard Hughes Medical Institute, and Section of Neurobiology, Yale University School of Medicine, New Haven, CT 06510; and Vertex Pharmaceuticals, Inc., Cambridge, MA 02139
  • K. S. Shindler
    Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110; Section of Immunobiology, Howard Hughes Medical Institute, and Section of Neurobiology, Yale University School of Medicine, New Haven, CT 06510; and Vertex Pharmaceuticals, Inc., Cambridge, MA 02139
  • T. S. Zheng
    Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110; Section of Immunobiology, Howard Hughes Medical Institute, and Section of Neurobiology, Yale University School of Medicine, New Haven, CT 06510; and Vertex Pharmaceuticals, Inc., Cambridge, MA 02139
  • K. Kuida
    Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110; Section of Immunobiology, Howard Hughes Medical Institute, and Section of Neurobiology, Yale University School of Medicine, New Haven, CT 06510; and Vertex Pharmaceuticals, Inc., Cambridge, MA 02139
  • R. A. Flavell
    Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110; Section of Immunobiology, Howard Hughes Medical Institute, and Section of Neurobiology, Yale University School of Medicine, New Haven, CT 06510; and Vertex Pharmaceuticals, Inc., Cambridge, MA 02139
  • P. Rakic
    Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110; Section of Immunobiology, Howard Hughes Medical Institute, and Section of Neurobiology, Yale University School of Medicine, New Haven, CT 06510; and Vertex Pharmaceuticals, Inc., Cambridge, MA 02139

書誌事項

公開日
2000-01-04
DOI
  • 10.1073/pnas.97.1.466
公開者
Proceedings of the National Academy of Sciences

この論文をさがす

説明

<jats:p> The number of neurons in the mammalian brain is determined by a balance between cell proliferation and programmed cell death. Recent studies indicated that Bcl-X <jats:sub>L</jats:sub> prevents, whereas Caspase-3 mediates, cell death in the developing nervous system, but whether Bcl-X <jats:sub>L</jats:sub> directly blocks the apoptotic function of Caspase-3 <jats:italic>in vivo</jats:italic> is not known. To examine this question, we generated <jats:italic>bcl-x</jats:italic> / <jats:italic>caspase-3</jats:italic> double mutants and found that <jats:italic>caspase-3</jats:italic> deficiency abrogated the increased apoptosis of postmitotic neurons but not the increased hematopoietic cell death and embryonic lethality caused by the <jats:italic>bcl-x</jats:italic> mutation. In contrast, <jats:italic>caspase-3</jats:italic> , but not <jats:italic>bcl-x</jats:italic> , deficiency changed the normal incidence of neuronal progenitor cell apoptosis, consistent with the lack of expression of Bcl-X <jats:sub>L</jats:sub> in the proliferative population of the embryonic cortex. Thus, although Caspase-3 is epistatically downstream to Bcl-X <jats:sub>L</jats:sub> in postmitotic neurons, it independently regulates apoptosis of neuronal founder cells. Taken together, these results establish a role of programmed cell death in regulating the size of progenitor population in the central nervous system, a function that is distinct from the classic role of cell death in matching postmitotic neuronal population with postsynaptic targets. </jats:p>

収録刊行物

被引用文献 (5)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ